New genomics tool could help predict tumor aggressiveness, treatment outcomes
Thursday, April 16, 2015 - 18:30
in Health & Medicine
A new method for measuring genetic variability within a tumor might one day help doctors identify patients with aggressive cancers that are more likely to resist therapy, according to a study led by researchers now at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James).